Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis

Angiogenesis. 2016 Apr;19(2):191-200. doi: 10.1007/s10456-016-9500-2. Epub 2016 Feb 22.

Abstract

Background: Vasculogenic mimicry (VM) is the formation of vascular channels by tumor cells or tumor cell-derived, trans-differentiated cells in highly aggressive, solid tumors. However, the disease features and prognostic value of VM for overall survival of cancer patients remain controversial.

Method: To systematically investigate the roles of VM in cancer progression and its prognostic values, we performed a meta-analysis based on 36 studies (33 eligible articles) including 3609 patients. The pooled hazard ratios (HRs) with 95 % confidence intervals (95 % CIs) were used to assess the relationship between VM and overall survival in cancer patients.

Results: Vasculogenic mimicry was significantly associated with cancer differentiation, lymph node metastasis, distant metastasis, and TNM stage. The prognostic value of VM was significant in overall survival (HR 2.16; 95 % CI 1.98-2.38; P < 0.001). Analyses stratified by confounders, such as cancer type, ethnicity, VM detection methods, sample size, and Newcastle-Ottawa quality score, found similar significant results.

Conclusions: The presence of VM predicts poorer survival outcomes in cancer patients.

Keywords: Angiogenesis; Meta-analysis; Solid tumor; Survival; Vasculogenic mimicry.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Heterogeneity
  • Humans
  • Neoplasms / blood supply*
  • Neoplasms / diagnosis*
  • Neovascularization, Pathologic / pathology*
  • Prognosis
  • Publication Bias
  • Survival Analysis